HLA genetic study in Iran Saqqez-Baneh Kurds: no genetic trace of Aryan invasions in Anatolian Turks and Kurds is found.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 21 07 2022
accepted: 23 07 2022
pubmed: 6 8 2022
medline: 19 10 2022
entrez: 5 8 2022
Statut: ppublish

Résumé

Kurds are living at Middle East region comprising several countries (38 million people) and also have emigrated to Asia, Europe and America. Kurds from Iran have been HLA typed in the present work from Saqqez and Baneh towns, Kordestan province, Iran. Origin of Kurds is considered autochthonous from Anatolia and surrounding mountains :they have been referred as "the mountain people" by classic Persian, Greek and Roman authors. Present day Turks are also autochthonous from Anatolia, but they were not recognized by classical authors as living in the mountains and they speak a language of Asian origin that was imposed to Anatolia by a "elite" invasion without a noticeable high Asian gene input. Most frequent class I and class II HLA alleles found in Iranian Kurds population are: HLA-A*24:02, A*02:01 and HLA-B*35:01, and HLA-DRB1*11:01, DRB1*03:02 and HLA-DQB1*03:01; also, most frequent HLA extended haplotypes from this Iran Kurdish sample are not shared with Iranians but with Mediterranean, Turkish and Caucasus people. This is confirmed by Neighbour-Joining and correspondence analysis studied together with the corresponding populations. Finally, our studies show that both Kurds and Turks are genetically original from Anatolian Peninsula and surrounding countries and that an apparent Asian genetic or Aryan invasion does not exist in the area.

Identifiants

pubmed: 35931633
pii: S0198-8859(22)00140-9
doi: 10.1016/j.humimm.2022.07.005
pii:
doi:

Substances chimiques

HLA-B Antigens 0
HLA-DQ beta-Chains 0
HLA-DRB1 Chains 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

737-738

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Fabio Suarez-Trujillo (F)

Departament of Immunology, University Complutense, School of Medicine, Madrid Regional Blood Center, Madrid, Spain.

Ignacio Juarez (I)

Departament of Immunology, University Complutense, School of Medicine, Madrid Regional Blood Center, Madrid, Spain.

José Palacio-Gruber (J)

Departament of Immunology, University Complutense, School of Medicine, Madrid Regional Blood Center, Madrid, Spain.

José Manuel Martín-Villa (J)

Departament of Immunology, University Complutense, School of Medicine, Madrid Regional Blood Center, Madrid, Spain.

Ali Amirzargar (A)

Molecular Immunology Research Center, Medical School, Tehran University of Medical Sciences, Tehran, Iran.

Antonio Arnaiz-Villena (A)

Departament of Immunology, University Complutense, School of Medicine, Madrid Regional Blood Center, Madrid, Spain. Electronic address: arnaizville@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH